Songlin Gan
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Songlin Gan has a total of 20 co-authors. Here are the top co-authors by number of shared publications:
- Albert Serra-Cardona
Institute for Cancer Genetics, Department of Pediatrics and Department of Genetics and Development, Columbia University Irving Medical Center, New York, NY 10019, USA
2 shared publications - Zhiguo Zhang
Institute for Cancer Genetics, Columbia University Irving Medical Center, New York, USA
2 shared publications - Andrei Chabes
Department of Medical Biochemistry and Biophysics, Umeå University, Umeå, Sweden
1 shared publication Chuanhe Yu
Department of Biochemistry and Molecular Biology, Mayo Clinic, Rochester, MN 55905, USA
1 shared publication- Chun-Long Chen
Institut Curie, PSL Research University, CNRS UMR3244, Dynamics of Genetic Information, Sorbonne Université, Paris, France
1 shared publication - Erik Johansson
Department of Medical Biochemistry and Biophysics, Umeå University
1 shared publication
Latest Publications
- Open Access
- 21 March 2025
- Published by MDPI AG in Biosensors
- Vol. 15 (4) , 199
Innovative Applications of Nanopore Technology in Tumor Screening: An Exosome-Centric Approach
Cancer remains one of the leading causes of death worldwide. Its complex pathogenesis and metastasis pose significant challenges for early diagnosis, underscoring the urgent need for innovative and non-invasive tumor screening methods. Exosomes, small extracellular vesicles that reflect the physiological and pathological states of their parent cells, are uniquely suited for cancer liquid biopsy due to their molecular cargo, including RNA, DNA, and proteins. However, traditional methods for exosome isolation and detection are often limited by inadequate sensitivity, specificity, and efficiency. Nanopore technology, characterized by high sensitivity and single-molecule resolution, offers powerful tools for exosome analysis. This review highlights its diverse applications in tumor screening, such as magnetic nanopores for high-throughput sorting, electrochemical sensing for real-time detection, nanomaterial-based assemblies for efficient capture, and plasmon resonance for ultrasensitive analysis. These advancements have enabled precise exosome detection and demonstrated promising potential in the early diagnosis of breast, pancreatic, and prostate cancers, while also supporting personalized treatment strategies. Additionally, this review summarizes commercialized products for exosome-based cancer diagnostics and examines the technical and translational challenges in clinical applications. Finally, it discusses the future prospects of nanopore technology in advancing liquid biopsy toward clinical implementation. The continued progress of nanopore technology not only accelerates exosome-based precision medicine but also represents a significant step forward in next-generation liquid biopsy and tumor screening.
- 21 March 2025
- Published by MDPI AG in Biosensors
- Vol. 15 (4) , 199
Open AccessInnovative Applications of Nanopore Technology in Tumor Screening: An Exosome-Centric Approach
Cancer remains one of the leading causes of death worldwide. Its complex pathogenesis and metastasis pose significant challenges for early diagnosis, underscoring the urgent need for innovative and non-invasive tumor screening methods. Exosomes, small extracellular vesicles that reflect the physiological and pathological states of their parent cells, are uniquely suited for cancer liquid biopsy due to their molecular cargo, including RNA, DNA, and proteins. However, traditional methods for exosome isolation and detection are often limited by inadequate sensitivity, specificity, and efficiency. Nanopore technology, characterized by high sensitivity and single-molecule resolution, offers powerful tools for exosome analysis. This review highlights its diverse applications in tumor screening, such as magnetic nanopores for high-throughput sorting, electrochemical sensing for real-time detection, nanomaterial-based assemblies for efficient capture, and plasmon resonance for ultrasensitive analysis. These advancements have enabled precise exosome detection and demonstrated promising potential in the early diagnosis of breast, pancreatic, and prostate cancers, while also supporting personalized treatment strategies. Additionally, this review summarizes commercialized products for exosome-based cancer diagnostics and examines the technical and translational challenges in clinical applications. Finally, it discusses the future prospects of nanopore technology in advancing liquid biopsy toward clinical implementation. The continued progress of nanopore technology not only accelerates exosome-based precision medicine but also represents a significant step forward in next-generation liquid biopsy and tumor screening.
- Open Access
- 28 August 2020
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 6 (35) , eabb5820
DNA polymerase α interacts with H3-H4 and facilitates the transfer of parental histones to lagging strands
DNA Pol α transfers parental histones to lagging strands.
- 28 August 2020
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 6 (35) , eabb5820
Open AccessDNA polymerase α interacts with H3-H4 and facilitates the transfer of parental histones to lagging strands
DNA Pol α transfers parental histones to lagging strands.
- 28 September 2018
- Published by American Association for the Advancement of Science (AAAS) in Science
- Vol. 361 (6409) , 1386-1389
A mechanism for preventing asymmetric histone segregation onto replicating DNA strands
How cells ensure symmetric inheritance: Parental histones with modifications are recycled to newly replicated DNA strands during genome replication, but do the two sister chromatids inherit modified histones equally? Yu et al. and Petryk et al. found in mouse and yeast, respectively, that modified histones are segregated to both DNA daughter strands in a largely symmetric manner (see the Perspective by Ahmad and Henikoff). However, the mechanisms ensuring this symmetric inheritance in yeast and mouse were different. Yeasts use subunits of DNA polymerase to prevent the lagging-strand bias of parental histones, whereas in mouse cells, the replicative helicase MCM2 counters the leading-strand bias. Science , this issue p. 1386 , p. 1389 ; see also p. 1311
- 28 September 2018
- Published by American Association for the Advancement of Science (AAAS) in Science
- Vol. 361 (6409) , 1386-1389
A mechanism for preventing asymmetric histone segregation onto replicating DNA strands
How cells ensure symmetric inheritance: Parental histones with modifications are recycled to newly replicated DNA strands during genome replication, but do the two sister chromatids inherit modified histones equally? Yu et al. and Petryk et al. found in mouse and yeast, respectively, that modified histones are segregated to both DNA daughter strands in a largely symmetric manner (see the Perspective by Ahmad and Henikoff). However, the mechanisms ensuring this symmetric inheritance in yeast and mouse were different. Yeasts use subunits of DNA polymerase to prevent the lagging-strand bias of parental histones, whereas in mouse cells, the replicative helicase MCM2 counters the leading-strand bias. Science , this issue p. 1386 , p. 1389 ; see also p. 1311